Latest

A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆

Markets · 15 min delay

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

ISEQ9,241.3▲ +0.62%

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

Updated 04 Jul 2026 · HPRA open data

Glenmark Pharmaceuticals s.r.o. — Licensed Medicines

11 medicines held by Glenmark Pharmaceuticals s.r.o. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

← All medicines · 11 products held by Glenmark Pharmaceuticals s.r.o.

Medicine	Active substance	Licence holder	Status
Olazax 10 mg tablets EU/1/09/597/003	Olanzapine	Glenmark Pharmaceuticals s.r.o.	—
Olazax 15 mg tablets EU/1/09/597/004	Olanzapine	Glenmark Pharmaceuticals s.r.o.	—
Olazax 20 mg tablets EU/1/09/597/005	Olanzapine	Glenmark Pharmaceuticals s.r.o.	—
Olazax 5 mg tablets EU/1/09/597/001	Olanzapine	Glenmark Pharmaceuticals s.r.o.	—
Olazax 7.5 mg tablets EU/1/09/597/002	Olanzapine	Glenmark Pharmaceuticals s.r.o.	—
Olazax Disperzi EU/1/09/592/002	Olanzapine	Glenmark Pharmaceuticals s.r.o.	—
Olazax Disperzi 10 mg orodispersible tablets EU/1/09/592/003	Olanzapine	Glenmark Pharmaceuticals s.r.o.	—
Olazax Disperzi 15 mg orodispersible tablets EU/1/09/592/004	Olanzapine	Glenmark Pharmaceuticals s.r.o.	—
Olazax Disperzi 20 mg orodispersible tablets EU/1/09/592/005	Olanzapine	Glenmark Pharmaceuticals s.r.o.	—
Olazax Disperzi 5 mg orodispersible tablets EU/1/09/592/001	Olanzapine	Glenmark Pharmaceuticals s.r.o.	—
Ryaltris 25 microgram/actuation + 600 microgram/actuation nasal spray, suspension PA1543/002/001	Mometasone furoate, Olopatadine	Glenmark Pharmaceuticals s.r.o.	Marketed

Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.